Taurine 2 pp 315-325 | Cite as

Effect of Taurine on Toxicity of the Pyrrolizidine Alkaloid Monocrotaline in Rats

  • Chong Chao Yan
  • Ryan J. Huxtable
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 403)

Abstract

The pyrrolizidine alkaloid (PA), monocrotaline, is found in a variety of Crotalaria species in the legume family13. It has been responsible for a large number of human intoxications, most dramatically in the Caribbean nations of Jamaica3, 11, 31. For many years, monocrotaline-induced veno-occlusive disease of the liver was endemic, due to the use of the leaves of C. spectabilis in the preparation of the so-called “bush teas” that were commonly consumed. It was not until the 1950s that the cause of the condition was established2 and control measures instituted.

Keywords

Pulmonary Arterial Hypertension Pyrrolizidine Alkaloid Decrease Body Weight Gain Serum Amino Acid Concentration Monocrotaline Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams, R. and Rogers, E.F. 1939, The structure of monocrotaline, the alkaloid in Crotalaria spectabilis and Crotalaria retusa, J.Amer. Chem.Soc. 61:2815–2819.CrossRefGoogle Scholar
  2. 2.
    Bras, G., Berry, D.M., and Gyorgy, P. 1957, Plants as aetiological factor in veno-occlusive disease of the liver, The Lancet, 960-962.Google Scholar
  3. 3.
    Bras, G., Jelliffe, D.B., and Stuart, K.L. 1954, Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica, Archives of Pathology, 57:285–300.Google Scholar
  4. 4.
    Chauvin, P., Dillon, J.-C., Moren, A., Talbak, S., and Barakaev, S. 1993, Heliotrope poisoning in Tadjikistan, Lancet, 341:1663.CrossRefGoogle Scholar
  5. 5.
    Estep, J.E., Lamé, M.W., Jones, A.D., and Segall, H.J. 1990, N-acetylcysteine-conjugated pyrrole identified in rat urine following administration of two pyrrolizidine alkaloids, monocrotaline and senecionine, Toxicol.Lett. 54:61–69.CrossRefGoogle Scholar
  6. 6.
    Fox, D.W., Hart, M.C., Bergeson, P.S., Jarrett, P.B., Stillman, A.E., and Huxtable, R.J. 1978, Pyrrolizidine (Senecio) intoxication mimicking Reye’s syndrome, J.Pediatr. 93:980–982.CrossRefGoogle Scholar
  7. 7.
    Gillis, C.N., Huxtable, R.J., and Roth, R.A. 1978, Effect of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and norepinephrine by perfused lung, Brit. J.Pharmacol. 63:435–443.CrossRefGoogle Scholar
  8. 8.
    Glowaz, S.L., Michnika, M., and Huxtable, R.J. 1992, Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline, Toxicol.Appl.Pharmacol. 115:168–173.CrossRefGoogle Scholar
  9. 9.
    Habig, W.H., Pabst, M.J., and Jakoby, W.B. 1974, Glutathione S-transferases: The first enzymatic step in mercapturic acid formation, J.Biol.Chem. 249:7130–7139.Google Scholar
  10. 10.
    Horecker, B.L. and Kornberg, A. 1948, The extinction coefficients of the reduced band of pyridine nucleotides, J.Biol.Chem. 175:385–390.Google Scholar
  11. 11.
    Huxtable, R.J. 1979, Pyrrolizidine alkaloids and the lung endothelium: a paradigm of lung damage resulting from circulating toxins, in: “Pyrrolizidine (senecio) alkaloids: toxicity, metabolism and poisonous plant control measures”, Cheeke, P.R. ed., Oregon State University, Corvallis, pp. 43-56.Google Scholar
  12. 12.
    Huxtable, R.J. 1980, Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States, Perspect.Biol.Med. 24:1–14.Google Scholar
  13. 13.
    Huxtable, R.J. 1989, Human health implications of pyrrolizidine alkaloids and herbs containing them, in: “Toxicants of Plant Origin, Vol I: Alkaloids”, Cheeke, P.R. ed., CRC Press, Boca Raton, Florida, pp. 41–86.Google Scholar
  14. 14.
    Huxtable, R.J. 1992, Physiological actions of taurine, Physiol.Rev. 72:101–163.Google Scholar
  15. 15.
    Huxtable, R.J. 1993, Hepatic nonaltruism and pulmonary toxicity of pyrrolizidine alkaloids, in: “Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells”, Gram, T.E. ed., Pergamon Press, New York, pp. 215–239.Google Scholar
  16. 16.
    Huxtable, R.J. 1996, Taurine: Past, present and future, in: “Taurine: Basic and Clinical Aspects”, Huxtable, R.J., Azuma, J., Nakagawa, M., Kuriyama, K. and Baba, A. eds., Plenum, New York.Google Scholar
  17. 17.
    Huxtable, R.J., Ciaramitaro, D., and Eisenstein, D. 1978, The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium, Mol.Pharmacol. 14:1189–1203.Google Scholar
  18. 18.
    Lafranconi, W.M., Ohkuma, S., and Huxtable, R.J. 1985, Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline, Toxicon, 23:983–992.CrossRefGoogle Scholar
  19. 19.
    Lawrence, R.A., Sunde, R.A., Schwartz, G.L., and Hoekstra, W.G. 1974, Glutathione peroxidase activity in rat lens and other tissues in relation to dietary selenium intake, Exp.Eye Res. 18:563–569.CrossRefGoogle Scholar
  20. 20.
    Massey, V. and Williams, C.H. 1965, On the reaction mechanism of yeast glutathione reductase, J.Biol.Chem. 240:4470–4480.Google Scholar
  21. 21.
    Mattocks, A.R. 1968, Toxicity of pyrrolizidine alkaloids, Nature (London), 217:723–728.CrossRefGoogle Scholar
  22. 22.
    Mattocks, A.R. 1972, Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids, Chem.-Biol.Interact. 5:227–242.CrossRefGoogle Scholar
  23. 23.
    Mattocks, A.R., Croswell, S., Jukes, R., and Huxtable, R.J. 1991, Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver, Toxicon, 29:409–415.CrossRefGoogle Scholar
  24. 24.
    McGee, J.O., Patrick, R.S., Wood, C.B., and Blumgart, L.H. 1976, A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption, J.Clin.Path. 29:788–794.CrossRefGoogle Scholar
  25. 25.
    Miranda, C.L., Reed, R.L., Guengerich, F.P., and Buhler, D.R. 1991, Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver, Carcinogenesis, 12:515–519.CrossRefGoogle Scholar
  26. 26.
    Nigra, L. and Huxtable, R.J. 1992, Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver, Toxicon, 30:1195–1202.CrossRefGoogle Scholar
  27. 27.
    Paglia, D.E. and Valentine, W.N. 1967, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J.Lab.Clin.Med. 70:158–169.Google Scholar
  28. 28.
    Ridker, P.M., Ohkuma, S., McDermott, W.V., Trey, C., and Huxtable, R.J. 1985, Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine-containing dietary supplements, Gastroenterology, 88:1050–1054.Google Scholar
  29. 29.
    Roulet, M., Laurini, R., Rivier, L., and Calame, A. 1988, Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea, J.Pediatr. 112:433–436.CrossRefGoogle Scholar
  30. 30.
    Stillman, A.E., Huxtable, R., Consroe, P., Kohnen, P., and Smith, S. 1977, Hepatic veno-occlusive disease due to pyrrolizidine poisoning in Arizona, Gastroenterology, 73:349–352.Google Scholar
  31. 31.
    Stuart, K.L. and Bras, G. 1957, Veno-occlusive disease of the liver, Quart.J.Med. 26:291–315.Google Scholar
  32. 32.
    Tandon, H.D., Tandon, B.N., and Mattocks, A.R. 1978, An epidemic of veno-occlusive disease of the liver in Afghanistan, Am.J.Gastroenterology, 70:607–613.Google Scholar
  33. 33.
    Thut, P.D., Hruska, R.E., Huxtable, R.J., and Bressler, R. 1976, Effect of taurine on eating and drinking behavior, in: “Taurine”, Huxtable, RJ. and Barbeau, A. eds., Raven Press, New York, pp. 357–364.Google Scholar
  34. 34.
    Williams, D.E., Reed, R.L., Kedzierski, B., Dannan, G.A., Guengerich, F.P., and Buhler, D.R. 1989, Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver, Drug Metab.Disp. 17:387–392.Google Scholar
  35. 35.
    Yan, C.C. and Huxtable, R.J. 1995, Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver, Toxicol.Appl.Pharmacol. 130:132–139.CrossRefGoogle Scholar
  36. 36.
    Yan, C.C. and Huxtable, R.J. 1995, Effects of the pyrrolizidine alkaloid, retrorsine, on sulfur metabolism in the liver, Proc. Western Pharmacol.Soc. 38:37–40.Google Scholar
  37. 37.
    Yan, C.C. and Huxtable, R.J. 1995, The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat, Toxicon, 33:627–634.CrossRefGoogle Scholar
  38. 38.
    Yan, C.C. and Huxtable, R.J. 1995, Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver, Life Sci. 57:617–626.CrossRefGoogle Scholar
  39. 39.
    Yan, C.C. and Huxtable, R.J. 1996, Effect of pyrrolizidine alkaloids on taurine and sulfur metabolism in the rat liver, in: “Taurine: Basic and Clinical Aspects”, Huxtable, R.J., Azuma, J., Nakagawa, M., Kuriyama, K. and Baba, A. eds., Plenum, New York.Google Scholar
  40. 40.
    Yan, C.C. and Huxtable, R.J. 1996, Effects of taurine and guanidinoethane sulfonate on right ventricular hypertrophy induced by the pyrrolizidine alkaloid, monocrotaline, Biochem.Pharmacol. 51:321–329.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Chong Chao Yan
    • 1
  • Ryan J. Huxtable
    • 1
  1. 1.Department of Pharmacology, College of MedicineUniversity of ArizonaTucsonUSA

Personalised recommendations